Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Trisomy 21 and the brain.

Robert E Mrak1, W Sue T Griffin

  • 1Department of Pathology, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA.

Journal of Neuropathology and Experimental Neurology
|August 5, 2004
PubMed
Summary

Down syndrome is linked to abnormal brain development and Alzheimer disease pathology. Overexpression of genes like beta-amyloid precursor protein (betaAPP) and S100B, along with Interleukin-1 (IL-1), drives these neurodegenerative changes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

When Two Worlds Collide: The Contribution and Association Between Genetics (APOEε4) and Neuroinflammation (IL-1β) in Alzheimer's Neuropathogenesis.

Cells·2025
Same author

The Seminal Role of the Proinflammatory Cytokine IL-1β and Its Signaling Cascade in Glioblastoma Pathogenesis and the Therapeutic Effect of Interleukin-1β Receptor Antagonist (IL-1RA) and Tolcapone.

International journal of molecular sciences·2025
Same author

Altered protein homeostasis in cardiovascular diseases contributes to Alzheimer's-like neuropathology.

Basic research in cardiology·2025
Same author

Rescue of ApoE4-related lysosomal autophagic failure in Alzheimer's disease by targeted small molecules.

Communications biology·2024
Same author

Spatiotemporal Cofilin Signaling, Microglial Activation, Neuroinflammation, and Cognitive Impairment Following Hemorrhagic Brain Injury.

Cells·2023
Same author

Glial Fibrillary Acidic Protein: A Biomarker and Drug Target for Alzheimer's Disease.

Pharmaceutics·2022

Area of Science:

  • Neuroscience
  • Genetics
  • Pathology

Background:

  • Down syndrome fetuses exhibit impaired neuronal dendritic development, termed 'tree in winter,' linked to mental retardation.
  • Adults with Down syndrome show significant neuronal loss and Alzheimer disease pathologies, including neurofibrillary and neuritic Abeta plaques.
  • These changes correlate with neuropsychological and physiological decline in older individuals with Down syndrome.

Purpose of the Study:

  • To investigate the roles of chromosome 21-based gene products (betaAPP, S100B) and Interleukin-1 (IL-1) in Down syndrome-related neurodegeneration.
  • To understand the contribution of these factors to dendritic abnormalities and Alzheimer disease pathogenesis.
  • To elucidate the neuroinflammatory component in Down syndrome and sporadic Alzheimer disease.

Main Methods:

Related Experiment Videos

  • Analysis of gene products implicated in Down syndrome neuropathology.
  • Correlation studies between gene overexpression and observed pathologies.
  • Investigation of Interleukin-1's role in upregulating key pathogenic factors.

Main Results:

  • Beta-amyloid precursor protein (betaAPP) gene triplication is necessary for Alzheimer pathology development in Down syndrome.
  • S100B is overexpressed lifelong in Down syndrome, causing dendritic abnormalities and correlating with Alzheimer pathology.
  • Interleukin-1 (IL-1) is overexpressed, upregulating betaAPP and S100B, and driving neuroinflammation.

Conclusions:

  • BetaAPP, S100B, and IL-1 are key players in the neurodevelopmental and neurodegenerative processes in Down syndrome.
  • These factors contribute to the "tree in winter" appearance and Alzheimer disease pathology.
  • Neuroinflammation, mediated by IL-1, is a significant component in the pathogenesis of Alzheimer disease in Down syndrome and sporadic cases.